Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-03-02

Clinical Trial Update: Assessment of Corneal Endothelial Function Following Hypoxic Stress [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial assessing corneal endothelial function after hypoxic stress in Fuchs' Endothelial Corneal Dystrophy was withdrawn (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Fuchs' Endothelial Corneal Dystrophy | Phase 1, Phase 2 | Status: WITHDRAWN